Skip to main content
Skip to main content
Home
Company
About Us
Executive Team
Board of Directors
Scientific & Clinical Advisors
Partners
Pipeline
Technology
EQ504
EQ302
Publications
Presentations
Investors
Investor Overview
Stock Information
Stock Chart
Analyst Coverage
Press Releases
Events & Presentations
Email Alerts & Contacts
SEC Filings
Corporate Governance
Governance Documents
Committee Composition
Investor FAQs
Careers
Contact Us
Search query
Presentation Details
Back
γc receptor antagonist, EQ102, prevents the NK and T cell-mediated responses driven by IL-15 and IL-21<span>Phoi Tiet, et. al.</span><span>American Association of Immunology</span><span>2023</span>
05/14/2023
Download this Press Release
PDF Format (opens in new window)
Phoi Tiet, et. al.
Conference:
American Association of Immunology
Year:
2023
